You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tenalisib

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral T Cell Lymphoma Trial in Houston (Tenalisib)

Withdrawn
  • Peripheral T Cell Lymphoma
  • Tenalisib
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 13, 2022

Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Batumi, Tbilisi (Tenalisib)

Active, not recruiting
  • Locally Advanced Breast Cancer
  • Metastatic Breast Cancer
  • Tenalisib
  • Batumi, Georgia
  • +2 more
May 2, 2022

Hematological Malignancies Trial in Georgia, Poland, United States (Tenalisib)

Enrolling by invitation
  • Hematological Malignancies
  • Tenalisib
  • San Francisco, California
  • +6 more
Nov 1, 2021

Leukemia, Lymphocytic, Chronic, B-Cell Trial in Bulgaria, Georgia, Poland (Tenalisib)

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Tenalisib
  • Pleven, Bulgaria
  • +5 more
Jul 22, 2021

Non Hodgkin Lymphoma Trial in Australia, United States (Tenalisib,)

Completed
Has Results
  • Non Hodgkin Lymphoma
  • Huntsville, Alabama
  • +11 more
Jul 20, 2021

Classical Hodgkin Lymphoma Trial in Chicago, Detroit, Seattle (Tenalisib, Pembrolizumab)

Terminated
  • Classical Hodgkin Lymphoma
  • Tenalisib
  • Pembrolizumab
  • Chicago, Illinois
  • +2 more
Dec 24, 2019

Healthy Trial in Quebec (RP6530)

Completed
Has Results
  • Healthy
  • Quebec, Canada
    Algorithme Pharma Inc
Nov 22, 2017

Lymphoma, B-Cell, T-Cell Lymphoma Trial in Paris, Milano (RP6530)

Completed
  • Lymphoma, B-Cell
  • T-Cell Lymphoma
  • Paris, France
  • +2 more
Jun 23, 2016